Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multiple-ascending dose study of CNTX-0290

Trial Profile

A multiple-ascending dose study of CNTX-0290

Phase of Trial: Phase I

Latest Information Update: 20 Jul 2017

At a glance

  • Drugs CNTX 0290 (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Jul 2017 New trial record
    • 18 Jul 2017 Data from this trial will be presented at an upcoming medical meeting according to a Centrexion Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top